CMG Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2019
Period Ending	Jun '26 Jun 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '19 Dec 31, 2019
Market Capitalization	165,879	274,691	245,561	334,730	298,618	590,292
Market Cap Growth	-47.77%	11.86%	-26.64%	12.09%	-49.41%	28.01%
Enterprise Value	227,596	305,502	239,371	285,069	182,746	466,997
Last Close Price	1122.00	1858.00	1768.00	2410.00	2150.00	4250.00
PE Ratio	-	-	91.13	51.85	-	193.46
PS Ratio	1.51	2.61	2.48	3.56	3.63	10.07
PB Ratio	0.82	1.36	1.30	1.76	1.62	3.28
P/TBV Ratio	0.85	1.40	1.33	1.82	1.64	3.30
P/OCF Ratio	-	-	846.50	84.99	60.48	209.07
EV/Sales Ratio	2.07	2.90	2.42	3.04	2.22	7.97
EV/EBITDA Ratio	-	-	54.82	50.96	34.71	99.16
EV/EBIT Ratio	-	-	234.60	93.87	61.30	179.35
Debt / Equity Ratio	0.44	0.36	0.42	0.14	0.04	0.00
Debt / EBITDA Ratio	-	-	18.31	4.67	1.27	0.06
Net Debt / Equity Ratio	0.31	0.23	0.02	-0.22	-0.38	-0.66
Net Debt / EBITDA Ratio	-25.97	-74.55	0.73	-7.63	-13.50	-25.33
Net Debt / FCF Ratio	-1.22	-1.12	-0.11	5.06	20.64	22.29
Asset Turnover	0.35	0.35	0.36	0.41	-	0.38
Inventory Turnover	1.65	1.66	2.41	2.40	-	3.38
Quick Ratio	0.83	0.60	1.46	3.80	4.58	15.12
Current Ratio	1.25	0.92	1.81	4.72	6.17	16.18
Return on Equity (ROE)	-4.30%	-5.15%	1.42%	3.44%	-	2.15%
Return on Assets (ROA)	-1.06%	-0.76%	0.23%	0.83%	-	1.06%
Return on Invested Capital (ROIC)	-2.07%	-1.68%	0.56%	2.23%	3.41%	3.74%
Return on Capital Employed (ROCE)	-2.20%	-1.80%	0.40%	1.40%	1.60%	1.40%
Earnings Yield	-5.05%	-3.67%	1.10%	1.93%	-0.13%	0.52%
FCF Yield	-30.41%	-14.80%	-11.32%	-2.52%	-1.15%	-0.91%
Payout Ratio	-	-	-	0.45%	-	-
Buyback Yield / Dilution	4.59%	73.24%	-288.03%	-	-14.27%	-11.63%